Keyphrases
Copeptin
100%
Liraglutide
100%
Adrenomedullin
100%
Polycystic Ovary Syndrome
100%
Atrial Natriuretic Peptide
100%
MR-proADM
50%
Heart Rate
40%
Cardiovascular Biomarkers
20%
Visceral Fat
20%
Placebo
20%
Insulin Resistance
20%
Percentage Difference
10%
Type 2 Diabetic Patients
10%
Cardiovascular Risk Markers
10%
Diastolic Blood Pressure
10%
Diuresis
10%
Type 2 Diabetes Prevention
10%
Vascular Tonus
10%
GLP-1 Receptor Agonist
10%
Cardiovascular Disease
10%
Regression Analysis
10%
Peptide Concentration
10%
Free Testosterone
10%
Placebo-controlled
10%
Body Composition
10%
Homeostasis
10%
Cardiovascular Risk
10%
Overweight Women
10%
Placebo Groups
10%
Cardiovascular Outcomes
10%
Subclinical Cardiovascular Disease
10%
Pharmacology, Toxicology and Pharmaceutical Science
Liraglutide
100%
Ovary Polycystic Disease
100%
Copeptin
100%
Atrial Natriuretic Factor
100%
Adrenomedullin
100%
Proadrenomedullin
50%
Placebo
40%
Biological Marker
40%
Cardiovascular Disease
30%
Randomized Controlled Trial
20%
Non Insulin Dependent Diabetes Mellitus
20%
Insulin Resistance
20%
Cardiovascular Risk
10%
Glucagon Like Peptide 1 Receptor Agonist
10%
Testosterone
10%
Obesity
10%